NCT06919809 2026-03-09
Effectiveness and Safety of X A-DERMâ„¢ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery
McGuire Institute
Phase NA Completed
McGuire Institute
Philogen S.p.A.
Replimune Inc.
AI Labs Group S.L
Highlight Therapeutics
Regeneron Pharmaceuticals